A dual VEGF-A and angiopoietin-2 inhibitor provided fast, durable treatment for wet age-related macular degeneration in a ...
The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results